Enkai Cell
恩凯赛药
Enkai Cell
Biotech/Healthcare
NK CellTech was established by a core technical team led by Academician Tian Zhigang. It focuses on the translation and development of innovative NK cell-based therapies and aims to provide patients with safer, more effective precision immunotherapies.
Latest round: Series A Extension (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-07-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.